Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Sihuan Pharma Climbs 25% In Hong Kong Trading Debut

publication date: Oct 28, 2010
Sihuan Pharmaceutical Holdings jumped 25% to HK$5.77 (US$.73) in the first day of trading following its IPO, giving more evidence that Hong Kong is the current worldwide center for warm receptions to pharmaceutical stock offerings. The company’s IPO was priced at HK$4.60, representing a forward P/E ratio of 27, and it hit a high of HK$6.05 in pre-market activity. Sihuan said demand for the offering was 481 times the number of shares in the deal. More details....

Stock Symbol: (HKEX: 0460)


Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital